Screenshot 2021 07 08 at 17.04.12 1 min
Screenshot 2021 07 08 at 17.04.12 1 min
3. Simplified Illustration of EEG measurement while conducting eye tracking min scaled
optoceutic hero about

Advancing New Technologies for

Brain Stimulation


Science & Research

Check out our publications and learn more about non-invasive brain stimulation

Get Involved with Our Research

previous arrow
next arrow

Advancing Innovative Digital Therapeutics Solutions

At Optoceutics, we are committed to developing disease-modifying digital therapeutics (DTx) for neurodegenerative and psychological disorders such as Alzheimer’s, MCI, ADHD, and depression.

We work at the intersection of neuroscience, engineering and artificial intelligence to create preventive health solutions that are safe, non-invasive and drug-free.

OB banner

Investigating Gamma Brain Waves for Alzheimer’s Disease

Optoceutics is currently conducting a clinical study to investigate the potential effect of masked 40 Hz flickering light on Alzheimer’s disease patients.

DISCLAIMER: All devices used in trials are considerd investigational devices and limited to investigational use only.


Sign-up to our newsletter and receive new information about our developments, clinical trials and more.

OB banner 1 e1626684760697

Selected Partners

Latest News

Read more about the team behind the project.

Where to Find Us